Assessing the efficacy of cidofovir against herpesvirus-induced genital lesions in goats using different therapeutic regimens

Antimicrobial Agents and Chemotherapy

Volumn 52, Issue 11, 2008, Pages 4064-4068

  Tempesta, M ^a   Crescenzo, G ^a   Camero, M ^a   Bellacicco, A L ^a   Tarsitano, E ^a   Decaro, N ^a   Neyts, J ^b   Martella, V ^a   Buonavoglia, C ^a  

^a UNIVERSITY OF BARI   (Italy)

^b REGA INSTITUTE FOR MEDICAL RESEARCH   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

CIDOFOVIR;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIVIRAL ACTIVITY; ARTICLE; CAPRINE HERPESVIRUS 1; CONTROLLED STUDY; CREAM; DRUG EFFICACY; FEMALE; GENITAL TRACT INFECTION; GENITAL ULCER; GOAT; HERPES SIMPLEX VIRUS 2; HERPES VIRUS; NONHUMAN; PRIORITY JOURNAL; TREATMENT RESPONSE; VAGINA MUCOSA; VIRUS SHEDDING; VIRUS TITRATION;

ANIMALS; ANTIVIRAL AGENTS; BASE SEQUENCE; CYTOSINE; DISEASE MODELS, ANIMAL; DNA PRIMERS; DNA, VIRAL; FEMALE; GENITAL DISEASES, FEMALE; GOAT DISEASES; GOATS; HERPES GENITALIS; HERPESVIRIDAE INFECTIONS; HUMANS; PHOSPHONIC ACIDS; SPECIES SPECIFICITY; VAGINAL CREAMS, FOAMS, AND JELLIES; VARICELLOVIRUS;

EID: 55849115258     PISSN: 00664804     EISSN: 10986596     Source Type: Journal    
DOI: 10.1128/AAC.00725-08     Document Type: Article

References (22)

1. Buonavoglia, C., M. Tempesta, A. Cavalli, V. Voigt, D. Buonavoglia, A. Conserva, and M. Corrente. 1996. Reactivation of caprine herpesvirus 1 in latently infected goats. Comp. Immunol. Microbiol. Infect. Dis. 19:275-281.
2. De Clercq, E. 2004. Antiviral drugs in current clinical use. J. Clin. Virol. 30:115-133.
3. De Clercq, E. 2007. The acyclic nucleoside phosphonates from inception to clinical use: historical perspective. Antivir. Res. 75:1-13.
4. De Clercq, E., and A. Holy. 2005. Acyclic nucleoside phosphonates: a key class of antiviral drugs. Nat. Rev. Drug Discov. 4:928-940.
5. Garré, B., K. van der Meulen, J. Nugent, J. Neyts, S. Croubels, P. De Backerand, and H. Nauwynck. 2007. In vitro susceptibility of six isolates of equine herpesvirus 1 to acyclovir, ganciclovir, cidofovir, adefovir, PMEDAP and foscarnet. Vet. Microbiol. 122:43-51.
6. Gibson, J. S., J. D. Slater, and H. J. Field. 1992. The activity of (S)-1(3-hydroxy-2-phosphonylmethoxypropyl) cytosine (HPMPC) against EHV-1 in cell cultures, mice and horses. Antivir. Res. 19:219-232.
7. Gibson, J. S., A. M. Thackray, and H. J. Field. 1993. The effect of (S)-1(3-hydroxy-2-phosphonylmethoxypropyl) cytosine (HPMPC) against EHV-1 in mice: primary and secondary infections. Antivir. Res. 20(Suppl. 1):130.
8. Gilliam, S. E., and H. J. Field. 1993. The effect of (S)-1(3-hydroxy-2-phosphonylmethoxypropyl) cytosine (HPMPC) on bovine herpesvirus-1 (BHV-1) infections and reactivation in cattle. Antivir. Res. 20:21-32.
9. Koptopoulos, G. 1992. Goat herpesvirus 1 infection: a review. Vet. Bull. 62:77-84.
10. Lafferty, W. E., R. W. Coombs, J. Benedetti, C. Critchlow, and L. Corey. 1987. Recurrences after oral and genital herpes simplex virus infection. Influence of site of infection and viral type. N. Engl. J. Med. 316:1444-1449.
11. Maggs, D. J., and H. E. Clarke. 2004. In vitro efficacy of ganciclovir, cidofovir, penciclovir, foscarnet, idoxuridine and acyclovir against feline herpesvirus type-1. Am. J. Vet. Res. 65:399-403.
12. Scagliarini, A., C. J. McInnes, L. Gallina, F. Dal Pozzo, L. Scagliarini, R. Snoeck, S. Prosperi, J. Sales, J. A. Gilray, and P. F. Nettleton. 2007. Antiviral activity of HPMPC (cidofovir) against orf virus infected lambs. Antivir. Res. 73:169-174.
13. Stragier, I., R. Snoeck, E. De Clercq, J. J. Van Den Oord, M. Van Ranst, and H. De Greef. 2002. Local treatment of HPV-induced skin lesions by cidofovir. J. Med. Virol. 67:241-245.
14. Tempesta, M., M. Camero, A. L. Bellacicco, E. Tarsitano, G. Crescenzo, J. Thiry, V. Martella, N. Decaro, G. Elia, J. Neyts, E. Thiry, and C. Buonavoglia. 2007. Potent inhibition of genital herpesvirus infection in goats by cidofovir. Antivir. Ther. 12:977-979.
15. Tempesta, M., M. Camero, A. L. Bellacicco, J. Thiry, G. Crescenzo, J. Neyts, E. Thiry, and C. Buonavoglia. 2007. Cidofovir is effective against caprine herpesvirus 1 infection in goats. Antivir. Res. 74:138-141.
16. Tempesta, M., G. Greco, A. Pratelli, D. Buonavoglia, M. Camero, V. Martella, and C. Buonavoglia. 2002. Reactivation of caprine herpesvirus 1 in experimentally infected goats. Vet. Rec. 150:116-117.
17. Tempesta, M., A. Pratelli, M. Corrente, and C. Buonavoglia. 1999. A preliminary study on the pathogenicity of a strain of caprine herpesvirus 1. Comp. Immunol. Microbiol. Infect. Dis. 22:137-143.
18. Tempesta, M., A. Pratelli, G. Greco, V. Martella, and C. Buonavoglia. 1999. Detection of caprine herpesvirus 1 in sacral ganglia of latently infected goat by PCR. J. Clin. Microbiol. 37:1598-1599.
19. Tempesta, M., P. Sagazio, A. Pratelli, M. G. De Palma, T. Corsalini, and C. Buonavoglia. 1998. Detection of caprine herpesvirus 1 by polymerase chain reaction, abstr. PD1-6, p. 414-415. Abstr. Proc. 8th World Conf. Anim. Prod.
20. Tempesta, M., E. Tarsitano, M. Camero, G. Greco, N. Decaro, G. Elia, V. Terio, and C. Buonavoglia. 2004. Short sequence repeats (SSR) in the glycoprotein C gene of caprine herpesvirus type 1 (CpHV-1), abstr. P14-23, p. 275. Abstr. Proc. 2nd Eur. Congr. Virol.
21. Yoshikawa, T., J. M. Hill, L. R. Stanberry, N. Bourne, J. F. Kurawadwala, and P. R. Krause. 1996. The characteristic site-specific reactivation phenotypes of HSV-1 and HSV-2 depend upon the latency-associated transcript region. J. Exp. Med. 184:659-664.
22. Zabawski, E. J., Jr. 2000. A review of topical and intralesional cidofovir. Dermatol. Online J. 6:3.